Browse > Article
http://dx.doi.org/10.15230/SCSK.2015.41.3.201

Development of Lecithin Organogel to Improve Solubility of Genistein  

Lee, Su Jin (R&D Center, LG Household & Healthcare Ltd.)
Kim, Jung A (R&D Center, LG Household & Healthcare Ltd.)
Kang, Nae Gyu (R&D Center, LG Household & Healthcare Ltd.)
Park, Sun Gyoo (R&D Center, LG Household & Healthcare Ltd.)
Lee, Cheon Koo (R&D Center, LG Household & Healthcare Ltd.)
Publication Information
Journal of the Society of Cosmetic Scientists of Korea / v.41, no.3, 2015 , pp. 201-208 More about this Journal
Abstract
Organogels are semi-solid systems that consist of an apolar solvent as the liquid phase within a three-dimensional networked structure. In this study, we developed a stable and skin penetration-enhanced Lecithin Organogel (LO) containing genistein, which is one of the poorly soluble active ingredients in both polar and apolar phase. After screening of various components (type of gelators, organic and aqueous phase), hydrogenated lecithin (HL), sunflower oil (SO), dipropylene glycol (DPG), and polyethylene glycol (PEG) were mainly used in this formulation. Phase ternary diagram was employed for optimization of the composition in the LO. The formulated LO were evaluated for its organoleptic characteristics, stability, pH, rheology, phase transition temperatures, microscopic analysis and skin penetration. The optimized stable LO system can be utilized as an effective and stable cosmetic formulation that can carry poorly soluble active ingredients at high concentration for topical dermal delivery.
Keywords
cosmetic; organogel; lecithin; skin penetration; genistein;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 D. Locati, S. Morandi, A. Cupisti, L. Ghiadoni, and A. Arnoldi, Characterization and quantification of soy isoflavone metabolites in serum of renal transplanted patients by high-performance liquid chromatography/electrospray ionization mass spectrometry, Rapid Commun. Mass Spectrom., 19(23), 3473 (2005).   DOI
2 W. Huachen, R. Bowen, Q. Cai, S. Barnes, and Y. Wang, Antioxidant and antipromotional effects of the soybean isoflavone genistein, Biol. Med., 208(1), 124 (1995).   DOI
3 W. A. Fritz, L. Coward, J. Wang, and C. A. Lamartiniere, Dietary genistein : perinatal mammary cancer prevention, bioavailability and toxicity testing in the rat, Carcinogenesis, 19(12), 2151 (1998).   DOI
4 M. Jurzak and K. Adamczyk, Drug biochemistry influence of genistein on c-jun, c-fos and fos-b of ap-1 subunits expression in skin keratinocytes, fibroblasts and keloid fibroblasts cultured in vitro, Acta Pol. Pharm., 70(2), 205 (2013).
5 Z. R. Huang, C. F. Hung, Y. K. Lin, and J. Y. Fang, In vitro and in vivo evaluation of topical delivery and potential dermal use of soy isoflavones genistein and daidzein, Int. J. Pharm., 364(1), 36 (2008).   DOI
6 S. R. Georgetti, R. Casagrande, W. Verri, R. F. V. Lopez, and M. J. V. Fonseca, Evaluation of in vivo efficacy of topical formulations containing soybean extract, Int. J. Pharm., 352(1-2), 189 (2008).   DOI
7 A. Vintiloiu and J. Leroux, Organogels and their use in drug delivery-a review, J. Control., 125(3), 179 (2008).   DOI
8 S. Sahooa, N. Kumarb, C. Bhattacharyac, S. S. Sagirid, K. Jaine, K. Palf, and B. Nayak, Organogels: properties and applications in drug delivery, Des. Monomers Polym., 14(2), 95 (2011).   DOI
9 Y. A. Shchipunov and E. Shumilina, Lecithin bridging by hydrogen bonds in the organogel, Mater. Sci. Eng., 3(1), 43 (1995).   DOI
10 Y. A. Shchipunov and E. Shumilina, Lecithin organogels: role of polar solvent and nature of intermolecular interactions, Colloid J. Russ. Acad. Sci., 58(1), 117 (1996).
11 R. Kumar and O. P. Katare, Lecithin organogels as a potential phospholipid-structured system for topical drug delivery: a review, AAPS Pharm. Sci. Tech., 6(2), E298 (2005).   DOI
12 H. Willimann, P. Walde, P. L. Luisi, A. Gazzaniga, and F. troppolo, Lecithin organogel as matrix for transdermal transport of drugs, J. Pharm. Sci., 81(9), 871 (1992).   DOI
13 D. Grace, J. Rogers, K. Skeith, and K. Anderson, Topical diclofenac versus placebo: a double blind, randomized clinical trial in patients with osteoarthritis of the knee, J. Rheumatol., 26(12), 2659 (1999).
14 P. Mahler, F. Mahler, H. Duruz, M. Ramazzina, V. Liguori, and G. Mautone, Double-blind, randomized, controlled study on the efficacy and safety of a novel diclofenac epolamine gel formulated with lecithin for the treatment of sprains, strains and contusions, Drugs Exp. Clin., 29(1), 45 (2003).
15 S. Bhatnagar and S. P. Vyas, Organogel-based system for transdermal delivery of propranolol, J. Microencapsul., 11(4), 431 (1994).   DOI
16 G. Spacca, A. Cacchio, A. Forgacs, P. Monteforte, and G. Rovetta, Analgesic efficacy of a lecithin-vehiculated diclofenac epolamine gel in shoulder periarthritis and lateral epicondylitis: a placebo-controlled, multicenter, randomized, double-blind clinical trial, Drugs Exp. Clin., 31(4), 147 (2005).
17 G. Agrawal, M. Juneja, S. Agrawal, S. K. Jain, and S. S. Pancholi, Preparation and characterization of reverse micelle based organogels of piroxicam. Die Pharm. Int. J. Pharm. Sci., 59(3), 191 (2004).
18 C. Nastruzzi and R. Gambari, Antitumor activity of (trans) dermally delivered aromatic tetra-amidines, J. Control Release., 29(1), 53 (1994).   DOI
19 R. Aboofazeli, H. Zia, and T. E. Needham, Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement, Drug Deliv., 9(4), 239 (2002).   DOI
20 I. Shaikh, K. R. Jadhav, P. S. Gide, V. J. Kadam, and S. S. Pisal, Topical delivery of aceclofenac from lecithin organogels: preformulation study, Curr. Drug Deliv., 3(4), 417 (2006).   DOI
21 F. Dreher and E. Wehrli, Interaction of a lecithin microemulsion gel with human stratum corneum and its effect on transdermal transport, J. Control Release., 45(2), 131 (1997).   DOI
22 D. Satapathy, D. Biswas, B. Behera, S. S. Sagiri, K. Pal, and K. Pramanik, Sunflower-oil-based lecithin organogels as matrices for controlled drug delivery, J. Appl. Polym. Sci., 129(2), 585 (2013).   DOI
23 N. Baran, V. K. Singh, K. Pal, A. Anis, D. K. Pradhan, and K. Pramanik, Development and characterization of soy lecithin and palm oil-based organogels, Polym. Plast. Technol. Eng., 53(9), 865 (2014).   DOI
24 S. F. Taveira, A. Nomizo, and R. F. Lopez, Effect of the iontophoresis of a chitosan gel on doxorubicin skin penetration and cytotoxicity, J. Control Release, 134(1), 35 (2009).   DOI
25 V. Agrawal, V. Gupta, S. Ramteke, and P. Trivedi, Preparation and evaluation of tubular micelles of pluronic lecithin organogel for transdermal delivery of sumatriptan, AAPS Pharm. Sci. Tech., 11(4), 1718 (2010).   DOI
26 M. Lescanne, P. Grondin, A. d'Aleo, F. Fages, J.-L. Pozzo, O. Mondain Nonval, P. Reinheimer, and A. Colin, Thixotropic organogels based on a simple N-hydroxyalkyl amide: rheological and aging properties, Langmuir, 20(8), 3032 (2004).   DOI
27 K. Choi, H. Son, and S. Lee, The effect of glossiness and lattice structure of wax matrixes on using n-parrafin and branched wax, J. Soc. Cosmet. Scientists Korea, 36(2), 99 (2010).
28 A. Bhatia, B. Singh, K. Raza, S. Wadhwa, and O. P. Katare, Tamoxifen-loaded lecithin organogel (LO) for topical application: development, optimization and characterization, Int. J. Pharm., 444(1-2), 47 (2013).   DOI
29 J. Varshosaz, S. Andalib, M. Tabbakhian, and N. Ebrahimzadeh, Development of lecithin nanoemulsion based organogels for permeation enhancement of metoprolol through rat skin, J. Nanomater., 2013, 1 (2013).
30 S. Pradhan, S. S. Sagiri, V. K. Singh, K. Pal, S. S. Ray, and D. K. Pradhan, Palm oil-based organogels and microemulsions for delivery of antimicrobial drugs, J. Appl. Polym. Sci., 131(6), 39979 (2014).
31 R. Scartazzini and P. L. Luisi, Organogels from lecithins, J. Phys. Chem., 40(2), 829 (1988).
32 L. M. Andrade, C. de Fatima Reis, L. Maione-Silva, J. Luiz V., A. A. Alonso, R. C. Serpa, R. N. Marreto, E. M. Lima, and S. F. Taveira, Impact of lipid dynamic behavior on physical stability, in vitro release and skin permeation of genistein-loaded lipid nanoparticles, Eur. J. Pharm. Biopharm., 88(1), 40 (2014).   DOI